Topchoice Medical Corp. Class A

Topchoice Medical Corp. Class A

SSSE:600763
35.76
CNY
+0.04
(+0.11%)
1.67EPS
23.12P/E
15.24BMarket Cap
Apr 23Next Earn
Topchoice Medical Corp. Class A
SSE:600763
(Shanghai Stock Exchange)

Recent

price

35.76

P/E

ratio

23.12

div

yld

0.08%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.55
0.71
0.85
1.04
1.29
1.71
1.94
2.64
3.46
4.29
4.66
6.19
6.05
6.37
6.42
6.5
6.99
Revenue per Share
0.11
0.16
0.2
0.22
0.24
0.28
0.3
0.49
0.74
1.04
1.1
1.56
1.22
1.12
1.12
1.12
1.47
Basic EPS, GAAP
0.13
0.14
0.17
0.2
0.06
0.23
0.14
0.62
0.51
1.18
1.2
1.27
0.55
0.74
0.96
1.26
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.05
0.03
0.12
0.08
0.05
0.05
0.03
0.01
0.03
0.34
0.47
0.03
Dividend per Share
0.57
0.73
0.93
1.16
1.4
1.52
1.82
2.21
2.93
4
4.79
6.41
7.37
8.49
9
9.47
9.51
Book Value per Share
0.44
0.6
0.8
1.02
1.26
1.38
1.69
2.08
2.8
3.86
4.65
6.27
7.23
8.25
8.66
8.91
8.96
Tangible Book Value per Share
444
446
447
446
454
447
454
446
447
450
448
449
449
447
447
448
447
Basic Weighted Avg Shares
243
316
379
463
584
763
879
1,180
1,546
1,931
2,088
2,781
2,719
2,847
2,874
2,913
3,124
Sales/Revenue/Turnover
28.35
30.82
31.46
29.83
23.97
24.39
20.45
24.38
28.59
32.73
31.43
33.81
27.37
24.77
24.35
24.51
26.71
Operating Margin (%)
7
9
10
13
15
38
47
50
56
61
63
154
173
189
203
194
- -
Depreciation Expense
49
70
91
100
110
124
136
217
332
466
493
703
548
500
501
502
658
Net Income, GAAP
27.84
26.97
23.54
26.19
23.02
26.87
20.73
19.52
18.21
19.76
19.87
19.33
16.57
18.4
17.57
16.6
17.75
Effective Tax Rate (%)
20.18
22.16
24.02
21.69
18.86
16.3
15.5
18.36
21.48
24.14
23.59
25.27
20.17
17.58
17.43
17.23
21.07
Profit Margin (%)
127
198
81
171
210
230
249
454
201
297
267
396
634
278
324
335
223
Working Capital
- -
- -
- -
- -
- -
295
260
480
416
320
613
1,131
1,013
1,194
1,234
739
662
LT Debt
264
359
454
564
686
760
899
1,099
1,448
1,986
2,348
3,144
3,618
4,132
4,359
4,569
4,691
Total Equity
19.6
21.63
22.2
19.18
17.32
13.62
11.48
15.95
19.91
23.3
19.25
20.03
12.86
11.01
9.95
10.14
12.71
Return on Invested Capital (%)
20.33
21.7
20.58
19.1
16.69
14.25
13.72
15.77
18.64
20.54
16.66
17.05
11.34
9.06
8.24
7.76
10.05
Return on Capital (%)
21.09
23.89
24.38
21.4
19.17
18.98
18.17
23.93
28.78
29.96
24.96
27.94
17.71
14.05
12.78
12.15
15.67
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
426
469
573
LT Borrowings
- -
- -
- -
LT Finance Leases
720
692
662
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
447
447
447
Market Capitalization
18,817
15,154
15,239

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,180
817
1,081
Cash, Cash Equivalents & STI
794
369
620
Accounts Receivable, Net
196
143
150
Inventories
25
38
39
Total Current Liabilities
689
728
858
Payables & Accruals
- -
- -
- -
ST Debt
426
469
573
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.12%
14.7%
4.82%
Free Cash Flow
46.59%
8.83%
31.02%
Net Income, GAAP
18.01%
2.45%
0.19%
Sales/Revenue/Turnover
15.14%
7.6%
1.37%
Total Cash Common Dividend
139.72%
250.75%
39.36%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
708
702
823
641
2,874
2025
745
704
- -
623
2,913
2026
755
831
915
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.39
0.31
0.42
0.01
1.12
2025
0.41
0.31
- -
-0.03
1.12
2026
0.42
0.61
0.47
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.32
- -
0.34
2025
- -
0.45
- -
0.01
0.47
2026
- -
- -
0.02
- -
- -
Business
Topchoice Medical Corporation operates primarily in the healthcare sector, specializing in dental, assisted reproductive, and ophthalmological medical services. The company offers a comprehensive range of dental healthcare services, including dental implants, orthodontics, pediatric dentistry, periodontics, endodontics, and cosmetic dentistry, delivered through a network of approximately 32 dental hospitals across China. It integrates advanced technologies such as digital dentistry, CAD/CAM systems, 3D printing for prosthetics, intraoral scanners, and CBCT imaging to enhance diagnostic accuracy and treatment outcomes. In assisted reproductive services, the company provides in-vitro fertilization (IVF), fertility preservation, and related treatments, utilizing cutting-edge techniques like preimplantation genetic testing (PGT) and advanced sperm selection methods. Ophthalmology services encompass diagnosis, treatment, and surgical solutions for cataracts, refractive errors, glaucoma, and retinal diseases, employing technologies including optical coherence tomography (OCT) and femtosecond lasers. Topchoice Medical also engages in medical equipment sales, daily necessities, disinfection products, and investment management. Founded in 1995 and headquartered in Hangzhou, China, Topchoice Medical serves primarily the Chinese market through its specialized clinics, contributing significantly to the privatized healthcare sector. The company emphasizes quality and innovation by adopting advanced medical technologies and practices to improve patient care and outcomes. Recent major developments include the acquisition of a 6% stake in Zhejiang Topchoice Eye Hospital Investment Management Co., Ltd., reflecting expansion in the ophthalmological segment, and a strategic equity buyback plan totaling CNY 50 million approved in 2024. The firm is actively expanding its network of dental and medical aesthetic clinics while integrating telemedicine services to enhance accessibility. It also focuses on research and development in dental technologies and reproductive medicine, including AI-assisted diagnostics and treatments. These moves align with its strategic goal to broaden its service offerings and deepen technological integration within its core healthcare segments over the last two years. These activities position Topchoice Medical as a growing leader in China's healthcare services industry, with a strong foothold in dental, reproductive, and ophthalmology markets, supported by innovation and strategic expansion initiatives.